DK3300729T3 - Terapeutiske sammensætninger indeholdende macitentan - Google Patents

Terapeutiske sammensætninger indeholdende macitentan Download PDF

Info

Publication number: DK3300729T3
Authority: DK; Denmark
Prior art keywords: compositions containing; therapeutic compositions; containing macitentan; macitentan; therapeutic
Prior art date: 2008-08-13

Application number

DK17191033.4T

Other languages

English (en)

Inventor

Martine Clozel

Original Assignee

Actelion Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-08-13

Filing date

2009-08-12

Publication date

2020-01-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41346591&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3300729(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-08-12 Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd

2020-01-20 Application granted granted Critical

2020-01-20 Publication of DK3300729T3 publication Critical patent/DK3300729T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5578—Eicosanoids, e.g. leukotrienes or prostaglandins having a pentalene ring system, e.g. carbacyclin, iloprost
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

DK17191033.4T 2008-08-13 2009-08-12 Terapeutiske sammensætninger indeholdende macitentan DK3300729T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IB2008053252		2008-08-13
EP09786912.7A EP2315587B1 (en)	2008-08-13	2009-08-12	Therapeutic compositions containing macitentan

Publications (1)

Publication Number	Publication Date
DK3300729T3 true DK3300729T3 (da)	2020-01-20

Family

ID=41346591

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK17191033.4T DK3300729T3 (da)	2008-08-13	2009-08-12	Terapeutiske sammensætninger indeholdende macitentan
DK09786912.7T DK2315587T3 (da)	2008-08-13	2009-08-12	Terapeutiske sammensætninger indeholdende macitentan

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK09786912.7T DK2315587T3 (da)	2008-08-13	2009-08-12	Terapeutiske sammensætninger indeholdende macitentan

Country Status (30)

Country	Link
US (3)	US8809334B2 (da)
EP (2)	EP2315587B1 (da)
JP (3)	JP5764061B2 (da)
KR (1)	KR101678699B1 (da)
CN (1)	CN102099026B (da)
AR (1)	AR073031A1 (da)
AU (1)	AU2009280843B2 (da)
BR (1)	BRPI0917661B8 (da)
CA (1)	CA2731370C (da)
CY (2)	CY1119826T1 (da)
DK (2)	DK3300729T3 (da)
ES (2)	ES2763176T3 (da)
HK (1)	HK1253355B (da)
HR (2)	HRP20171917T1 (da)
HU (2)	HUE047767T2 (da)
IL (1)	IL211143A0 (da)
LT (2)	LT3300729T (da)
MA (1)	MA32614B1 (da)
MX (1)	MX350011B (da)
MY (1)	MY178894A (da)
NO (1)	NO2315587T3 (da)
NZ (1)	NZ591601A (da)
PL (2)	PL2315587T3 (da)
PT (2)	PT2315587T (da)
RU (1)	RU2519161C2 (da)
SI (2)	SI2315587T1 (da)
SM (2)	SMT201700592T1 (da)
TW (1)	TWI446911B (da)
WO (1)	WO2010018549A2 (da)
ZA (1)	ZA201101900B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007031933A2 (en)	2005-09-12	2007-03-22	Actelion Pharmaceuticals Ltd	Stable pharmaceutical composition comprising a pyrimidine-sulfamide
MX2010001837A (es)	2007-08-17	2010-03-10	Actelion Pharmaceuticals Ltd	Derivados de 4-pirimidinasulfamida.
ES2817557T3 (es) *	2008-02-28	2021-04-07	Nippon Shinyaku Co Ltd	Inhibidor de fibrosis
WO2010018549A2 (en)	2008-08-13	2010-02-18	Actelion Pharmaceuticals Ltd	Therapeutic compositions containing macitentan
US9505737B2 (en)	2013-01-11	2016-11-29	Corsair Pharma, Inc.	Treprostinil derivative compounds and methods of using same
JP6542128B2 (ja)	2013-01-11	2019-07-10	コルセアファーマインコーポレイテッド	トレプロスチニルのプロドラッグ
US9643911B2 (en)	2015-06-17	2017-05-09	Corsair Pharma, Inc.	Treprostinil derivatives and compositions and uses thereof
US9394227B1 (en)	2015-06-17	2016-07-19	Corsair Pharma, Inc.	Treprostinil derivatives and compositions and uses thereof
US9794795B1 (en)	2016-04-29	2017-10-17	Corning Optical Communications Wireless Ltd	Implementing a live distributed antenna system (DAS) configuration from a virtual DAS design using an original equipment manufacturer (OEM) specific software system in a DAS
US10912778B2 (en)	2016-12-14	2021-02-09	Respira Therapeutics, Inc.	Methods for treatment of pulmonary hypertension
BR112021003256A2 (pt) *	2018-09-14	2021-05-18	Pharmosa Biopharm Inc.	composição farmacêutica, método para tratar uma doença respiratória e método para reduzir o efeito colateral de uma droga de ácido fraco
MA54522B1 (fr)	2018-12-21	2024-07-31	Actelion Pharmaceuticals Ltd	Macitentan pour le traitement de l'hypertension artérielle pulmonaire
TW202042818A (zh)	2019-01-25	2020-12-01	瑞士商艾克泰聯製藥有限公司	用於治療慢性血栓性肺高血壓之醫藥組成物
KR20220106974A (ko)	2019-11-29	2022-08-01	액테리온 파마슈티칼 리미티드	폐동맥 고혈압을 치료하는 방법
AU2020408323A1 (en)	2019-12-16	2022-08-11	Tenax Therapeutics, Inc.	Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HF-pEF)
US20250064799A1 (en)	2021-12-31	2025-02-27	Tenax Therapeutics, Inc.	Oral formulations of levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1097239A (en)	1976-05-11	1981-03-10	Salvador Moncada	Enzymatic preparation of prostacyclin and its salts
DE2845770A1 (de) *	1978-10-19	1980-04-30	Schering Ag	Neue prostacyclin-derivate und verfahren zu ihrer herstellung
JPS58124778A (ja)	1982-01-20	1983-07-25	Toray Ind Inc	５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体
US4683330A (en) *	1984-03-08	1987-07-28	The Upjohn Company	Interphenylene carbacyclin derivatives
BRPI0116237B8 (pt) *	2000-12-18	2021-05-25	Actelion Pharmaceuticals Ltd	"composto de sulfamida, composição farmacêutica contendo o mesmo e seu uso como medicamento antagonista de receptor de endotelina".
JP2004516270A (ja) *	2000-12-19	2004-06-03	メルクパテントゲゼルシャフトミットベシュレンクテルハフトング	ピラゾロ〔４，３−ｄ〕ピリミジンおよび抗血栓剤、カルシウム拮抗剤、プロスタグランジンまたはプロスタグランジン誘導体を含む医薬製剤
DE10100426B4 (de)	2001-01-08	2006-04-06	Steag Hamatech Ag	Verfahren und Vorrichtung zum Zusammenfügen von Substraten
TWI316055B (da) *	2001-04-26	2009-10-21	Nippon Shinyaku Co Ltd
WO2004017993A1 (en)	2002-08-12	2004-03-04	Actelion Pharmaceuticals Ltd	Combination of prostacyclin or prostacyclin analogues and endothelin receptor antagonists for the treatment of pulmonary arterial hypertension
AU2003285321B2 (en) *	2002-12-02	2010-04-08	Actelion Pharmaceuticals Ltd	Pyrimidine-sulfamides and their use as endothelian receptor antagonist
US20050101608A1 (en) *	2003-09-24	2005-05-12	Santel Donald J.	Iloprost in combination therapies for the treatment of pulmonary arterial hypertension
TW200628467A (en) *	2004-11-11	2006-08-16	Actelion Pharmaceuticals Ltd	Novel sulfamides
WO2007031933A2 (en)	2005-09-12	2007-03-22	Actelion Pharmaceuticals Ltd	Stable pharmaceutical composition comprising a pyrimidine-sulfamide
AR062501A1 (es) *	2006-08-29	2008-11-12	Actelion Pharmaceuticals Ltd	Composiciones terapeuticas
PL2254570T3 (pl) *	2008-02-20	2014-05-30	Actelion Pharmaceuticals Ltd	Połączenie zawierające paklitaksel do leczenia raka jajnika
WO2010018549A2 (en)	2008-08-13	2010-02-18	Actelion Pharmaceuticals Ltd	Therapeutic compositions containing macitentan

2009
- 2009-08-12 WO PCT/IB2009/053553 patent/WO2010018549A2/en not_active Ceased
- 2009-08-12 PT PT97869127T patent/PT2315587T/pt unknown
- 2009-08-12 TW TW098127151A patent/TWI446911B/zh active
- 2009-08-12 SI SI200931770T patent/SI2315587T1/en unknown
- 2009-08-12 EP EP09786912.7A patent/EP2315587B1/en not_active Revoked
- 2009-08-12 HR HRP20171917TT patent/HRP20171917T1/hr unknown
- 2009-08-12 EP EP17191033.4A patent/EP3300729B1/en not_active Revoked
- 2009-08-12 PT PT171910334T patent/PT3300729T/pt unknown
- 2009-08-12 AR ARP090103113A patent/AR073031A1/es not_active Application Discontinuation
- 2009-08-12 DK DK17191033.4T patent/DK3300729T3/da active
- 2009-08-12 SM SM20170592T patent/SMT201700592T1/it unknown
- 2009-08-12 KR KR1020117003547A patent/KR101678699B1/ko active Active
- 2009-08-12 AU AU2009280843A patent/AU2009280843B2/en active Active
- 2009-08-12 ES ES17191033T patent/ES2763176T3/es active Active
- 2009-08-12 JP JP2011522608A patent/JP5764061B2/ja not_active Expired - Fee Related
- 2009-08-12 NO NO09786912A patent/NO2315587T3/no unknown
- 2009-08-12 PL PL09786912T patent/PL2315587T3/pl unknown
- 2009-08-12 MY MYPI2011000637A patent/MY178894A/en unknown
- 2009-08-12 LT LTEP17191033.4T patent/LT3300729T/lt unknown
- 2009-08-12 ES ES09786912.7T patent/ES2652590T3/es active Active
- 2009-08-12 CA CA2731370A patent/CA2731370C/en active Active
- 2009-08-12 HU HUE17191033A patent/HUE047767T2/hu unknown
- 2009-08-12 SI SI200932016T patent/SI3300729T1/sl unknown
- 2009-08-12 BR BRPI0917661A patent/BRPI0917661B8/pt not_active IP Right Cessation
- 2009-08-12 SM SM20190740T patent/SMT201900740T1/it unknown
- 2009-08-12 US US13/058,639 patent/US8809334B2/en active Active
- 2009-08-12 RU RU2011109084/15A patent/RU2519161C2/ru active
- 2009-08-12 NZ NZ591601A patent/NZ591601A/xx unknown
- 2009-08-12 HU HUE09786912A patent/HUE036071T2/hu unknown
- 2009-08-12 LT LTEP09786912.7T patent/LT2315587T/lt unknown
- 2009-08-12 MX MX2011001625A patent/MX350011B/es active IP Right Grant
- 2009-08-12 DK DK09786912.7T patent/DK2315587T3/da active
- 2009-08-12 PL PL17191033T patent/PL3300729T3/pl unknown
- 2009-08-12 CN CN2009801279936A patent/CN102099026B/zh not_active Expired - Fee Related
2011
- 2011-02-10 IL IL211143A patent/IL211143A0/en active IP Right Grant
- 2011-03-07 MA MA33675A patent/MA32614B1/fr unknown
- 2011-03-11 ZA ZA2011/01900A patent/ZA201101900B/en unknown
2014
- 2014-07-18 US US14/335,657 patent/US9173881B2/en active Active
2015
- 2015-06-12 JP JP2015119021A patent/JP5956026B2/ja active Active
- 2015-06-12 JP JP2015119020A patent/JP5956025B2/ja active Active
- 2015-10-02 US US14/873,787 patent/US9597331B2/en active Active
2018
- 2018-01-19 CY CY20181100074T patent/CY1119826T1/el unknown
- 2018-10-03 HK HK18112650.6A patent/HK1253355B/en not_active IP Right Cessation
2019
- 2019-12-06 HR HRP20192204TT patent/HRP20192204T1/hr unknown
2020
- 2020-01-08 CY CY20201100016T patent/CY1122641T1/el unknown

Also Published As

Publication number	Publication date
JP5956026B2 (ja)	2016-07-20
WO2010018549A2 (en)	2010-02-18
AR073031A1 (es)	2010-10-06
BRPI0917661B1 (pt)	2019-12-17
MX2011001625A (es)	2011-03-29
NZ591601A (en)	2012-12-21
JP2015180683A (ja)	2015-10-15
EP3300729A1 (en)	2018-04-04
RU2011109084A (ru)	2012-09-20
ES2763176T3 (es)	2020-05-27
HUE036071T2 (hu)	2018-06-28
HK1253355B (en)	2020-06-19
US20160022678A1 (en)	2016-01-28
PT3300729T (pt)	2020-01-20
JP5764061B2 (ja)	2015-08-12
SI3300729T1 (sl)	2020-02-28
MY178894A (en)	2020-10-21
US20140329824A1 (en)	2014-11-06
CA2731370C (en)	2017-03-14
TWI446911B (zh)	2014-08-01
BRPI0917661B8 (pt)	2021-05-25
JP5956025B2 (ja)	2016-07-20
CN102099026B (zh)	2012-08-29
EP2315587B1 (en)	2017-10-25
KR20110045006A (ko)	2011-05-03
SMT201700592T1 (it)	2018-03-08
MX350011B (es)	2017-08-22
PT2315587T (pt)	2018-01-31
HRP20171917T1 (hr)	2018-02-09
LT2315587T (lt)	2018-01-10
PL2315587T3 (pl)	2018-03-30
EP3300729B1 (en)	2019-10-09
CY1119826T1 (el)	2018-06-27
HRP20192204T1 (hr)	2020-03-06
US8809334B2 (en)	2014-08-19
ZA201101900B (en)	2012-08-29
NO2315587T3 (da)	2018-03-24
HK1253355A1 (en)	2019-06-14
AU2009280843B2 (en)	2015-03-05
AU2009280843A1 (en)	2010-02-18
US9173881B2 (en)	2015-11-03
JP2011530581A (ja)	2011-12-22
US9597331B2 (en)	2017-03-21
TW201010985A (en)	2010-03-16
SI2315587T1 (en)	2018-04-30
CN102099026A (zh)	2011-06-15
CY1122641T1 (el)	2021-03-12
EP2315587A2 (en)	2011-05-04
WO2010018549A3 (en)	2010-07-29
PL3300729T3 (pl)	2020-04-30
LT3300729T (lt)	2020-01-10
ES2652590T3 (es)	2018-02-05
CA2731370A1 (en)	2010-02-18
DK2315587T3 (da)	2018-01-02
JP2015187148A (ja)	2015-10-29
BRPI0917661A2 (pt)	2015-12-01
HUE047767T2 (hu)	2020-05-28
IL211143A0 (en)	2011-04-28
SMT201900740T1 (it)	2020-01-14
US20110136818A1 (en)	2011-06-09
KR101678699B1 (ko)	2016-11-23
RU2519161C2 (ru)	2014-06-10
MA32614B1 (fr)	2011-09-01

Publication	Publication Date	Title
DK3300729T3 (da)	2020-01-20	Terapeutiske sammensætninger indeholdende macitentan
BRPI1011587A2 (pt)	2016-03-22	compostos e composições terapèuticas
DK2634231T3 (da)	2022-09-19	Sammensætninger
BRPI0906749A2 (pt)	2015-07-07	Composição
BRPI0913808A2 (pt)	2017-06-20	composição
DE602008002756D1 (de)	2010-11-04	Bauzusammensetzung
ES2628203T8 (es)	2021-08-23	Composiciones antitranspirantes
BRPI0810634A2 (pt)	2014-10-07	Composições fungicidas
BRPI0914746A2 (pt)	2019-09-24	composições fungicidas
BRPI0917231A2 (pt)	2015-11-10	composição
IT1392101B1 (it)	2012-02-09	Composizione comprendente isoflavoni
FR2933868B1 (fr)	2012-08-17	Compositions cosmetiques
EP2236149A4 (en)	2012-12-26	MEDICAL COMPOSITION
DK2966175T3 (da)	2019-07-01	Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
DK2285413T3 (da)	2012-08-27	Farmaceutisk sammensætning
EP2335669A4 (en)	2016-05-11	COMPOSITION FOR MEANS FOR DESENSIBILIZING TEETH
BRPI0921313A2 (pt)	2015-12-29	composição farmaucêutica
BRPI0811002A2 (pt)	2015-01-27	Composição biofertilizante
EP2357204A4 (en)	2012-06-27	COMPOSITION
BRPI0912171A2 (pt)	2017-10-31	composição farmacêutica
EP2249776A4 (en)	2014-01-08	SHOWER COMPOSITIONS
BRPI0921301A2 (pt)	2015-12-29	composição farmacêutica
BRPI0917584A2 (pt)	2015-11-17	composição
BRPI0909764A2 (pt)	2015-10-06	compostos terapêuticos
BRPI0920692A2 (pt)	2015-12-29	composição